Filter News
Area of Research
- (-) Neutron Science (20)
- Advanced Manufacturing (1)
- Biological Systems (1)
- Biology and Environment (66)
- Biology and Soft Matter (1)
- Clean Energy (97)
- Climate and Environmental Systems (2)
- Computational Biology (2)
- Computational Engineering (2)
- Fusion and Fission (7)
- Fusion Energy (7)
- Isotopes (7)
- Materials (33)
- Materials for Computing (11)
- Mathematics (1)
- National Security (12)
- Nuclear Science and Technology (16)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Supercomputing (47)
- Transportation Systems (2)
News Type
News Topics
- (-) Biomedical (12)
- (-) Climate Change (1)
- (-) Coronavirus (8)
- (-) Transportation (4)
- 3-D Printing/Advanced Manufacturing (6)
- Artificial Intelligence (6)
- Big Data (2)
- Bioenergy (6)
- Biology (6)
- Biotechnology (1)
- Chemical Sciences (3)
- Clean Water (2)
- Composites (1)
- Computer Science (13)
- Cybersecurity (1)
- Decarbonization (2)
- Energy Storage (6)
- Environment (7)
- Fossil Energy (1)
- Frontier (1)
- Fusion (1)
- High-Performance Computing (2)
- Machine Learning (3)
- Materials (14)
- Materials Science (23)
- Mathematics (1)
- Microscopy (3)
- Nanotechnology (9)
- National Security (2)
- Neutron Science (98)
- Nuclear Energy (3)
- Physics (9)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (6)
- Security (2)
- Space Exploration (3)
- Summit (6)
- Sustainable Energy (2)
Media Contacts
Scientists at ORNL used neutrons to end a decades-long debate about an enzyme cancer uses.
How do you get water to float in midair? With a WAND2, of course. But it’s hardly magic. In fact, it’s a scientific device used by scientists to study matter.
Currently, the biggest hurdle for electric vehicles, or EVs, is the development of advanced battery technology to extend driving range, safety and reliability.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
In the quest for advanced vehicles with higher energy efficiency and ultra-low emissions, ORNL researchers are accelerating a research engine that gives scientists and engineers an unprecedented view inside the atomic-level workings of combustion engines in real time.
Six ORNL scientists have been elected as fellows to the American Association for the Advancement of Science, or AAAS.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.